sulfoquinovosyl dipalmitoyl glyceride: P-selectin receptor inhibitor; isolated from the alga Dictyochloris fragrans; structure in first source
ID Source | ID |
---|---|
PubMed CID | 159321 |
CHEMBL ID | 504516 |
SCHEMBL ID | 6925719 |
MeSH ID | M0276384 |
Synonym |
---|
sulfonoglycolipid |
brn 1279617 |
2,3-bis((1-oxohexadecyl)oxy)propyl 6-deoxy-6-sulfo-alpha-d-glucopyranoside |
sulfoquinovosyl dipalmitoyl glyceride |
alpha-d-glucopyranoside, 2,3-bis((1-oxohexadecyl)oxy)propyl 6-deoxy-6-sulfo- |
109430-50-4 |
sulfonoquinovosyl dipalmitoyl glyceride |
CHEMBL504516 , |
[(2s,3s,4s,5r,6s)-6-[2,3-di(hexadecanoyloxy)propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid |
bdbm50292392 |
SCHEMBL6925719 |
DTXSID40911161 |
1,2-dipalmitoyl-3-o-alpha-6'''-sulfoquinovosylglycerol |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
P-selectin | Homo sapiens (human) | IC50 (µMol) | 5.0000 | 5.0000 | 5.0000 | 5.0000 | AID403206 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
lipopolysaccharide binding | P-selectin | Homo sapiens (human) |
integrin binding | P-selectin | Homo sapiens (human) |
calcium ion binding | P-selectin | Homo sapiens (human) |
protein binding | P-selectin | Homo sapiens (human) |
heparin binding | P-selectin | Homo sapiens (human) |
sialic acid binding | P-selectin | Homo sapiens (human) |
fucose binding | P-selectin | Homo sapiens (human) |
glycosphingolipid binding | P-selectin | Homo sapiens (human) |
calcium-dependent protein binding | P-selectin | Homo sapiens (human) |
oligosaccharide binding | P-selectin | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
extracellular space | P-selectin | Homo sapiens (human) |
plasma membrane | P-selectin | Homo sapiens (human) |
external side of plasma membrane | P-selectin | Homo sapiens (human) |
platelet dense granule membrane | P-selectin | Homo sapiens (human) |
platelet alpha granule membrane | P-selectin | Homo sapiens (human) |
extracellular space | P-selectin | Homo sapiens (human) |
external side of plasma membrane | P-selectin | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID403206 | Displacement of immobilized sulfatide from P-selectin transfected in african green monkey COS cells by IgG-based competitive ELISA | 1997 | Journal of natural products, Apr, Volume: 60, Issue:4 | Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans. |
AID403208 | Inhibition of human P-selectin-dependent adhesion of activated platelets to HL60 cells after 30 mins by flow cytometry | 1997 | Journal of natural products, Apr, Volume: 60, Issue:4 | Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans. |
AID403207 | Inhibition of human P-selectin receptor globulin adhesion to HL60 cells | 1997 | Journal of natural products, Apr, Volume: 60, Issue:4 | Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.76) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |